29 Apr 2022 , 03:52 PM
Net profit of Solara Active Pharma Sciences declined 96.68% to Rs 1.88 crore in the quarter ended March 2022 as against Rs 56.65 crore during the previous quarter ended March 2021. Sales declined 18.77% to Rs 360.82 crore in the quarter ended March 2022 as against Rs 444.21 crore during the previous quarter ended March 2021.
For the full year,net loss reported to Rs 58.15 crore in the year ended March 2022 as against net profit of Rs 221.40 crore during the previous year ended March 2021. Sales declined 21.56% to Rs 1268.34 crore in the year ended March 2022 as against Rs 1616.88 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 360.82 | 444.21 | -19 | 1268.34 | 1616.88 | -22 |
OPM % | 3.75 | 22.31 | – | 6.31 | 23.87 | – |
PBDT | -1.87 | 84.06 | PL | 24.71 | 330.16 | -93 |
PBT | -29.69 | 56.62 | PL | -87.61 | 221.50 | PL |
NP | 1.88 | 56.65 | -97 | -58.15 | 221.40 | PL |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.